Intellectual Property Law

HB Ad Slot
HB Mobile Ad Slot

Intellectual property applies to many different areas of the legal world. Applying for patents for work-products, by individual employees, trademark laws, copyrights, and how companies leverage their IP asset-rights over employees, are just a few of the many areas the National Law Review covers as it pertains to IP.

Intellectual Property Litigation

Intellectual Property disputes are a complex area of law, often involving deep dives into complex concepts to understand the issues at play. In the United States, the United States Patent and Trademark Office (USPTO/PTO) is the agency involved in registering patents and trademarks.   As part of the USPTO, the Patent Trial and Appeal Board settles patent disputes, using a variety of mechanisms to settle issues related to intellectual property.    Some of the mechanisms include inter partes review, post-grant procedures, and covered business method patent reviews.  Issues related to the America Invents Act are also settled through the PTAB. The National Law Review covers changes to standards held by the USPTO in litigation and other patent issues.  The Trademark Trial and Appeal Board settles disputes related to trademarks, such as an ex parte appeal from the denial of an application for registration by an examining attorney, and an inter partes opposition, cancellation, concurrent use, or interference proceeding.  Other agencies involved in patent disputes are the International Trade Commission (ITC) or the Federal Trade Commission (FTC).  The National Law Review covers patent news as it relates to Supreme Court (SCOTUS) and federal circuit courts’ appeals, as well as general patent litigation and new patent filings.

Intellectual Property in Drug Patents

Legal analysis related to drug patents and pharmaceuticals and the interplay with intellectual property issues are also covered by the National Law Review.   Drug patents, biosimilars, generic top-level domain registration (gTLD), trade secrets, non-compete clauses, and other patent application news are updated on the site regularly. Additionally, tangential issues that impact pharmaceutical companies, such as innovator liability and related litigation, are also analyzed by the legal experts who write for the National Law Review. 

Intellectual Property in an Employment Context

The National Law Review has legal analysis on the intersection between intellectual property rights and employment, and who owns ideas, the Work Made For Hire principle as well resulting litigation. Additionally, legislation such as the Defense of Trade Secrets Act and its impact on workplaces, and ongoing litigation related to the legislation is also covered.

International Intellectual Property

Visitors to the site will oftentimes read about international news as it relates to patent applications in the US, and internationally as well. Pharmaceutical patents in Brazil, medical device patent applications from the United Kingdom, or litigation from the European Union, China, India, and other international sectors, are often covered online. Visitors will find the latest coverage, news, and insights on patent applications and litigation, when visiting the National Law Review, for up-to-date practice-area news.

National Law Review Intellectual Property/Patent Law TwitterFor hourly updates on the latest news about Intellectual Property Law, IP Litigation, Patent Legislation, and more, be sure to follow our IP Law Twitter feed, and sign up for complimentary e-news bulletins.

Recent Intellectual Property, Patent, Trademark & Copyright News

Title
Custom text Organization Sort descending
Mar
2
2015
European Trade Secrets Directive Looks to Unify and Strengthen Protection of Proprietary Business Information in the EU
Oct
23
2021
Trade Secret Implications of Facebook’s Frances Haugen’s Testimony: Do NDAs Protect Trade Secrets Against Whistleblowers?
Feb
19
2018
Federal Circuit: Rare Guidance on Subject Matter Eligibility of Software Claims
Jun
1
2018
SAS Institute: One Month In
May
16
2016
Auto Industry Has New Weapon To Protect Its Secrets
Jun
21
2016
Lessons For Persuading the Patent Board: Straight From Judges’ Mouths
Sep
29
2020
PTAB Waits as Supreme Court Considers Arthrex Certiorari Petitions
May
4
2017
Par’s Hatch-Waxman Claims Too Speculative and Discovery Requests Too Broad
Jul
16
2015
PTAB Average Time-To-Decision in IPRs May Surprise You
Jun
22
2023
First Rule of the PTAB? Play by the Rules
May
13
2020
The United States Patent and Trademark Office Remains Operational and Flexible During the COVID-19 Pandemic
Aug
2
2017
Fairness in Evaluation: Federal Circuit Remand Back to Board For Failure to Fully Consider Petitioner’s Arguments Against Motion to Amend
Aug
17
2015
Fifth Circuit Upholds Copyright Preemption of Trade Secret-Related Claims
Oct
30
2018
Can the Government Challenge Patents via AIA Proceedings? — Return Mail Gets Cert.
Jan
20
2016
U.S. Supreme Court Accepts Appeal of First Inter Partes Review Decision: Could Mark Significant Turning Point in Claim Construction at PTAB
May
20
2016
Pssst, The Secret Is Knowing What You Can’t Do With The Defend Trade Secrets Act
Jan
9
2017
Simple Steps to Help Keep Your Trade Secrets Safe
May
17
2021
License Agreement Not Enough for Standing on Appeal of an IPR Apple Inc. v. Qualcomm Inc.
Aug
14
2009
Protecting Your IP in a Troubled Economy: A Modest (and Cost-Effective) Proposal
Sep
3
2015
Federal Circuit Court Finds Dow Claims Clearly Indefinite
May
8
2018
USPTO Announces Notice of Proposed Rulemaking for Claim Construction Standard used in PTAB Proceedings
Mar
29
2016
The Estoppel Effects of IPR May Be Significantly Limited
Jun
21
2016
U.S. Supreme Court Upholds Broadest Reasonable Interpretation Standard, Affirms Federal Circuit’s Lack of Authority to Review Inter Partes Review Institution Decisions
Aug
17
2017
Car Manufacturers and Suppliers Are Not the Only Ones Who Should Be Worried About Autonomous Vehicles
Jul
13
2015
Thieves Among Us? Protecting Trade Secrets From Employee Theft
Jun
15
2018
SAS "Ground" Rules
Aug
9
2018
When the Words of a Claim Don’t Matter - Federal Circuit Extends Printed Matter Doctrine to Information and Mental Steps in Affirming PTAB’s Obviousness Determination
Dec
29
2015
Don't Blame Patents For High Drug Prices
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins